메뉴 건너뛰기




Volumn 97, Issue 2, 2010, Pages 241-245

Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme

Author keywords

Glioblastoma multiforme; Imatinib mesylate; Intratumoral concentration; Malignant glioma

Indexed keywords

IMATINIB;

EID: 77950461290     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0008-0     Document Type: Article
Times cited : (44)

References (19)
  • 1
    • 0034665138 scopus 로고    scopus 로고
    • Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylami-nopyrimidine class
    • Kilic T, Alberta JA, Zdunek PR et al (2000) Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylami-nopyrimidine class. Cancer Res 60(18):5143-5150
    • (2000) Cancer Res , vol.60 , Issue.18 , pp. 5143-5150
    • Kilic, T.1    Alberta, J.A.2    Zdunek, P.R.3
  • 2
    • 33644830094 scopus 로고    scopus 로고
    • Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme
    • Reardon DA, Egorin MJ, Quinn JA et al (2005) Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol 23(36):9359-9368
    • (2005) J Clin Oncol , vol.23 , Issue.36 , pp. 9359-9368
    • Reardon, D.A.1    Egorin, M.J.2    Quinn, J.A.3
  • 5
    • 53749096014 scopus 로고    scopus 로고
    • Phase II study of imatinib in patients with recurrent gliomas of varying histologies: A European Organization for Research and Treatment of Cancer Brain Tumor Group Study
    • Raymond E, Brandes AA, Dittrich C et al (2008) Phase II study of imatinib in patients with recurrent gliomas of varying histologies: a European Organization for Research and Treatment of Cancer Brain Tumor Group Study. J Clin Oncol 26(28):4659-4665
    • (2008) J Clin Oncol , vol.26 , Issue.28 , pp. 4659-4665
    • Raymond, E.1    Brandes, A.A.2    Dittrich, C.3
  • 6
    • 1342330066 scopus 로고    scopus 로고
    • Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571)
    • DOI 10.1080/10428190310001625728
    • Leis JF, Stepan DE, Curtin PT et al (2004) Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571). Leuk Lymphoma 45(4):695-698 (Pubitemid 38256028)
    • (2004) Leukemia and Lymphoma , vol.45 , Issue.4 , pp. 695-698
    • Leis, J.F.1    Stepan, D.E.2    Curtin, P.T.3    Ford, J.M.4    Peng, B.5    Schubach, S.6    Druker, B.J.7    Maziarz, R.T.8
  • 10
    • 34548068014 scopus 로고    scopus 로고
    • Exposure to phytoestrogens in the perinatal period affects androgen secretion by testicular Leydig cells in the adult rat
    • Akingbemi BT, Braden TD, Kemppainen BW et al (2007) Exposure to phytoestrogens in the perinatal period affects androgen secretion by testicular Leydig cells in the adult rat. Endocrinology 148(9):4475-4488
    • (2007) Endocrinology , vol.148 , Issue.9 , pp. 4475-4488
    • Akingbemi, B.T.1    Braden, T.D.2    Kemppainen, B.W.3
  • 11
    • 26444621412 scopus 로고    scopus 로고
    • Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: A patient series
    • DOI 10.1093/annonc/mdi317
    • Dresemann G (2005) Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series. Ann Oncol 16(10):1702-1708 (Pubitemid 41510147)
    • (2005) Annals of Oncology , vol.16 , Issue.10 , pp. 1702-1708
    • Dresemann, G.1
  • 12
    • 33751521850 scopus 로고    scopus 로고
    • Influence of hydroxyurea on imatinib mesylate (Gleevec) transport at the mouse blood-brain barrier
    • Bihorel S, Camenisch G, Gross G, Lemaire M, Scherrmann JM (2006) Influence of hydroxyurea on imatinib mesylate (Gleevec) transport at the mouse blood-brain barrier. Drug Metab Dispos 34(12):1945-1949
    • (2006) Drug Metab Dispos , vol.34 , Issue.12 , pp. 1945-1949
    • Bihorel, S.1    Camenisch, G.2    Gross, G.3    Lemaire, M.4    Scherrmann, J.M.5
  • 13
    • 34548278289 scopus 로고    scopus 로고
    • Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier
    • DOI 10.1111/j.1471-4159.2007.04808.x
    • Bihorel S, Camenisch G, Lemaire M, Scherrmann JM (2007) Influence of breast cancer resistance protein (Abcg2) and p-gly-coprotein (Abcb1a) on the transport of imatinib mesylate (Glee-vec) across the mouse blood-brain barrier. J Neurochem 102(6):1749-1757 (Pubitemid 47329285)
    • (2007) Journal of Neurochemistry , vol.102 , Issue.6 , pp. 1749-1757
    • Bihorel, S.1    Camenisch, G.2    Lemaire, M.3    Scherrmann, J.-M.4
  • 15
    • 53749086477 scopus 로고    scopus 로고
    • Biochemical evidence of tumor response and measurable levels of the drug in glioblastoma tissue from patients treated with imatinib
    • Abstract
    • Razis E, Selviaridis P, Fletcher J et al (2007) Biochemical evidence of tumor response and measurable levels of the drug in glioblastoma tissue from patients treated with imatinib. J Clin Oncol 25(18S):2023 (Abstract
    • (2007) J Clin Oncol , vol.25 , Issue.18 S
    • Razis, E.1    Selviaridis, P.2    Fletcher, J.3
  • 16
    • 72049088625 scopus 로고    scopus 로고
    • Tumor sequestration of lapatinib (NABTC 04-01)
    • Kuhn J, Robins HI, Mehta M et al (2008) Tumor sequestration of lapatinib (NABTC 04-01). Neuro Oncol 10(5):783 (Abstract
    • (2008) Neuro Oncol , vol.10 , Issue.5 , pp. 783
    • Kuhn, J.1    Robins, H.I.2    Mehta, M.3
  • 17
    • 27744506881 scopus 로고    scopus 로고
    • Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
    • Lassman AB, Rossi MR, Raizer JJ et al (2005) Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res 11(21):7841-7850
    • (2005) Clin Cancer Res , vol.11 , Issue.21 , pp. 7841-7850
    • Lassman, A.B.1    Rossi, M.R.2    Raizer, J.J.3
  • 18
    • 37549070324 scopus 로고    scopus 로고
    • Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma
    • Kuhn JG, Chang SM, Wen PY et al (2007) Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res 13(24):7401-7406
    • (2007) Clin Cancer Res , vol.13 , Issue.24 , pp. 7401-7406
    • Kuhn, J.G.1    Chang, S.M.2    Wen, P.Y.3
  • 19
    • 38849208347 scopus 로고    scopus 로고
    • Anti-tumor activity of rapamycin in a phase i trial for patients with recurrent PTEN-deficient glioblastoma
    • Cloughesy TF, Yoshimoto K, Nghiemphu P et al (2008) Anti-tumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 5(1):e8
    • (2008) PLoS Med , vol.5 , Issue.1
    • Cloughesy, T.F.1    Yoshimoto, K.2    Nghiemphu, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.